<!doctype html>
<html ⚡>
<head>
  <meta charset="utf-8">
  <title>The Perfect Clot and How to Block It!</title>
  <link rel="canonical" href="https://heartrhythmbox.com/afupdate/">
  <meta name="viewport" content="width=device-width,minimum-scale=1,initial-scale=1">
  <meta name="author" content="t'Thon">
  <meta name="description" content="NOAC Update 2023">
  <style amp-boilerplate>body{-webkit-animation:-amp-start 8s steps(1,end) 0s 1 normal both;-moz-animation:-amp-start 8s steps(1,end) 0s 1 normal both;-ms-animation:-amp-start 8s steps(1,end) 0s 1 normal both;animation:-amp-start 8s steps(1,end) 0s 1 normal both}@-webkit-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-moz-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-ms-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@-o-keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}@keyframes -amp-start{from{visibility:hidden}to{visibility:visible}}</style><noscript><style amp-boilerplate>body{-webkit-animation:none;-moz-animation:none;-ms-animation:none;animation:none}</style></noscript>

  <script async src="https://cdn.ampproject.org/v0.js"></script>
  <script custom-element="amp-carousel" src="https://cdn.ampproject.org/v0/amp-carousel-0.1.js" async></script>
  
  <script async custom-element="amp-analytics" src="https://cdn.ampproject.org/v0/amp-analytics-0.1.js"></script>
  <script async custom-element="amp-auto-ads"
        src="https://cdn.ampproject.org/v0/amp-auto-ads-0.1.js"></script>
  <script async custom-element="amp-selector" src="https://cdn.ampproject.org/v0/amp-selector-0.1.js"></script>
  <script async custom-element="amp-video" src="https://cdn.ampproject.org/v0/amp-video-0.1.js"></script>
  <script async custom-element="amp-youtube" src="https://cdn.ampproject.org/v0/amp-youtube-0.1.js"></script>
  <link href="https://fonts.googleapis.com/css?family=Raleway:wght@400;800&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.14.0/css/all.css" integrity="sha384-HzLeBuhoNPvSl5KYnjx0BT+WB0QEEqLprO+NBkkk5gbc67FTaL7XIGa2w1L0Xbgc" crossorigin="anonymous">
  <link rel="icon" href="box coral.png" type="image/png" sizes="60x60">

  <!--amp ad-->
  <script async custom-element="amp-ad" src="https://cdn.ampproject.org/v0/amp-ad-0.1.js"></script>
  <style amp-custom>

    /*color*/
  .lightGrey {background-color: #d8d8d8}
  .lightBlue {background-color: #afbdc8;}
  .blue {background-color: #5a7995}
  .darkBlue {background-color: #19283d;color: white;}
  .creme {background-color: #e0d9be;}
  .coral {background-color: #fa7268;}
  /*other color #353535 #cc6e71*/

    #title {
        text-align: left;font-size: 6vmax;color:#e0d9be;
        padding:30vh 1vmax 1vmax 1vmax;
        width: fit-content;margin-left: auto;margin-right: auto;
    }

    #titleBg {width: 100%;height: 100vh;
    background: #19283d url(heartGraphic.png) no-repeat;
    background-size: 40vw;background-position: 2vw 10vh;}


    #how2Blk {
        font-size: 3vmax;color: #d8d8d8;text-align: right;line-height: 70%;
    }
    #hrbTitle {text-align: right;padding: 5vh 0;}

    
    .row {display: flex;}

    @media only screen and (max-width:900px){
      #title {text-align: center;}
      #titleBg{
        background: #19283d url(heartGraphicStraight.png) no-repeat;
        background-size:100vw;
        background-position: 0vw 20vh;
      }
    }
    
    @media only screen and (max-width:600px) {
      .row {flex-wrap: wrap;}
      #how2Blk {text-align: center;}
      #hrbTitle {text-align: center;}
    }
    .container, .container img {
      background-color: transparent;
    }
    .contain img {
      object-fit: contain;
    }
    
    .container {
     position: relative;
     width: 72vw;
     height: 45vw;
    }

    .conclusion {
      background: #232323 url(media/heartRing.png) no-repeat center;
      background-size: 70vw;
      position: relative;
      width: 72vw;
      height: 45vw;
    }
    .conclusion li {
      padding: 1vh 2vw;
    }
    

    .headLine {font-size: 2.8vmax;text-align: center;margin-left: auto;margin-right: auto;color: #19283d;line-height: 120%;
      padding-top: 8vmax;padding-bottom:0.5vh;padding-left: 0.5vh;padding-right: 0.5vh;
      max-width: 900px;width: fit-content;border-bottom: #fa7268 solid 0.25vmax;}
  

    amp-carousel {margin-top: 1vh;max-width: 73vw;margin-left: auto;margin-right: auto;
    max-height: 46vw;background-color:transparent;}
    
    
    .caption {font-family: Raleway, sans-serif;font-size: 1.8vmax;max-width: 900px;margin-right: auto;margin-left: auto;
    padding: 0.8vmax 1vmax 3vmax 1vmax;text-align: center;color:#19283d;}

    @media only screen and (max-width:1024px){
      .container, .conclusion {width: 96vw;height:54vw;}
      .conclusion li {padding-top: 1vh;}
      amp-carousel {max-height: 55vw;max-width: 97vw;}
    }

    amp-selector[role=tablist].tabs {display: flex;justify-content: center;}
    amp-selector[role=tablist].tabs [selected] {outline: none;
      background-color: #19283d;border:#19283d 0.1vmax solid;}

    .dots  {
    width:1.2vmin;
    height:1.2vmin;
    border-radius:1.2vmin;
    background-color:none;border:#19283d 0.1vmax solid;
    display:inline-block;margin: 0 0.2vmax;
    }
    
    #strokeTable {
      overflow-x: scroll;text-align: center;border-collapse: collapse;
    }
    #strokeTable tr:first-of-type {font-weight: 600;background-color: #e0d9be;}
    #strokeTable tr:nth-of-type(2) {font-weight: 600;background-color: #e0d9be;}
    #strokeTable td {font-size: 2vmax;border-bottom: #19283d solid 0.1vmax;}

    #mhvTable {overflow-x: scroll;text-align: left;font-size: 1.8vmax;border-collapse: collapse;}
    #mhvTable tr:first-of-type, #mhvTable tr:nth-of-type(2) {
      font-weight: 600;background-color:#19283d;color: #e0d9be;
    }
    #mhvTable td {font-size: 1.8vmax;border-bottom: #5a7995 solid 0.1vmax;}

    #ckdTable {
      overflow-x: scroll;text-align: center;border-collapse: collapse;
    }
    #ckdTable tr:first-of-type {font-weight: 600;background-color: #19283d;
      color:#d8d8d8;
    }
    #ckdTable td {font-size: 1.8vmax;border: #5a7995 solid 0.1vmax;}

    .ref{position: absolute;bottom: 1%;right: 1%;
      font-size: 1vmax;color: #ddd;background-color: rgba(0,0,0,0.7);
    }

    table, tr, th {padding: 1vmax;}
    td {padding: 0.5vmax;}
    th, tr, td {border:solid #ddd 0.1vmax;font-size: 1.5vmax;}
  
     
</style>

</head>

<body style="font-family: Raleway, sans-serif;">
  <amp-auto-ads type="adsense"
  data-ad-client="ca-pub-1548733331544768">
  </amp-auto-ads>
  <amp-analytics type="googleanalytics" config="https://amp.analytics-debugger.com/ga4.json" data-credentials="include">
    <script type="application/json">
    {
        "vars": {
                    "GA4_MEASUREMENT_ID": "G-PHBZ8EJY6J",
                    "GA4_ENDPOINT_HOSTNAME": "www.google-analytics.com",
                    "DEFAULT_PAGEVIEW_ENABLED": true,    
                    "GOOGLE_CONSENT_ENABLED": false,
                    "WEBVITALS_TRACKING": false,
                    "PERFORMANCE_TIMING_TRACKING": false,
                    "SEND_DOUBLECLICK_BEACON": false
        }
    }
    </script>
    </amp-analytics>


<!--title section-->


<div id="titleBg">

  <!--title topic-->

  <div id="title">
    <div style="font-size: 3vmax;color:#5a7995;font-weight:800;">
        NOAC Update 2023
    </div>
    <div id='clot'>THE PERFECT CLOT</div>
    <div id="how2Blk">
        and how to block it!</div>

    <div id="hrbTitle">
        <a href="https://heartrhythmbox.com" 
        style="cursor: pointer;text-decoration: none;color: #777;">
            <amp-img src="boxGrey.png" width="3vh" height="3vh" layout='fixed'>
            </amp-img>
            <span style="vertical-align: 3px;font-size: 2.5vh;">
                HeartRhythmBox.com</span>
        </a>
        </div>
  </div>





</div>  


<!--content-->
<!--1.0 coag cascasde-->
  <div class="lightGrey"> 

  <div class="headLine">
    The perfect clot requires adequate <b>COAGULATION FACTORS</b>
  </div>

  <amp-carousel id="carousel1"
      height="1200"
      layout="fixed-height"
      type="slides"
      on="slideChange:carousel1Selector.toggle(index=event.index, value=true)">

      <!--coag cascade-->
      <div class="container">
        <!--amp-video controls noaudio autoplay loop 
        class="contain" layout="fill" title="coagCascade"
            <source src="video/coagCascade2.mp4" type="video/mp4">
        </amp-video-->
        <amp-youtube constrols noaudio autoplay loop
        data-videoid="DMUl_0ucmZk"
        layout="fill"
        class="contain">
        </amp-youtube>
      </div>

    <!--OAC-->
    <div class="container">
    <amp-video controls noaudio autoplay loop 
    class="contain" layout="fill" title="OAC"
        <source src="video/OACs.mp4" type="video/mp4">
    </amp-video>
    </div>

  </amp-carousel>

  <amp-selector id="carousel1Selector" class="tabs" role=tablist on="select:carousel1.goToSlide(index=event.targetOption)">
    <div option='0' class="dots" selected></div>
    <div option='1' class="dots"></div>

  
  </amp-selector>

  <div class="caption">
  1. Coagulation cascade concept consists of intrinsic and extrinsic pathway.<br>
  2. One molecule of Factor X produces 1000 molecules of Thrombin (Factor II), so called "Thrombin Burst".<br>
  3. Vitamin K antagonist inhibits production of multiple coagulation factors.   
  </div>
  </div>

<!--1.1 early OAC after ischemic stroke-->
<div class="lightGrey"> 

  <div class="headLine">
    Can NOAC be resumed early after acute ischemic stroke with AF?
  </div>

  <amp-carousel id="carousel11"
      height="1200"
      layout="fixed-height"
      type="slides"
      on="slideChange:carousel11Selector.toggle(index=event.index, value=true)">

      <!--VKA-->
      <div class="container">
        <div style="overflow-y: scroll;height: 100%;">
          <div class="darkBlue" style="padding: 1vmax;text-align: center;
          font-size: 3vmax;color: #fa7268;font-weight: 900;">
           Problems with Vitamin K Antagonist (VKA)
          </div>
          <ul style="padding-top: 1vmax;font-size: 2.5vmax;color: #19283d;">
            <li>10% of intracranial bleeding is VKA related.</li>
            <li style="padding-top: 0.5vmax;">Brain is the only organ with high expression of tissue factor 
                but low expression of tissue factor pathyway inhibitor.</li>
            <li style="padding-top: 0.5vmax;">
                In a patient with AF with acute ischemic stroke, 
                OAC is recommended to resume at least 1wk and 2wks after moderate and major stroke respectively.
            </li>
            <li style="padding-top: 0.5vmax;">
                Recent RCTs suggest that earlier resumption of NOAC was not inferior to delayed start.
            </li>
          </ul>
          <div class="ref">
          <a href="https://doi.org/10.1161/STROKEAHA.113.000736" target="_blank" style="color: inherit;">
            Stroke 2013
          </a> , 
          <a href="https://doi.org/10.1177/1076029612454938" target="_blank" style="color: inherit;">
            Clinical and Applied Thrombosis/Hemostasis. 2013
          </a> , and
          <a href="https://doi.org/10.1016/0049-3848(90)90148-6" target="_blank" style="color:inherit">
            Thromb Haemost 1999.
            </a>
          </div>
        </div>
       
      </div>
    
      <!--OAC after stroke-->
      <div class="container">
        <amp-img src="media/oacAfterStroke.png"
        layout="fill"
        class="contain"></amp-img>
        
        <div class="ref">
        <a href="https://doi.org/10.1093/eurheartj/ehy136" target="_blank" style="color: inherit;">
          1. 2018 EHRA Practical Guide
          </a> &nbsp;
        <a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2303048" target="_blank" style="color: inherit;">
            2. ELAN. NEJM 2023.
        </a> &nbsp;
        <a href="https://doi.org/10.1161/CIRCULATIONAHA.122.060666" target="_blank" style="color: inherit;">
            3. TIMING. Circulation 2022.
        </a>
        </div>
      </div>

      <!--ELAN TIMING-->
      <div class="container">
        <div style="overflow-y: scroll;height: 100%;">
          <div style="padding: 0.5vmax;text-align: center;
          font-size: 2.5vmax;color:#19283d;font-weight: 900;">
           Early initiation was noninferior to delayed start of NOAC after
           acute ischemic stroke in patients with AF.
          </div>
          <table id="strokeTable">
              <tr>
                <td rowspan="2">Trials</td>
                <td colspan="2">Composite Endpoints (early vs. delayed)</td>
                <td rowspan="2">Intracranial Hemorrhage (early vs. delayed)</td>
              </tr>
              <tr>
                <td>at 30d</td>
                <td>at 90d</td>
              </tr>
              <tr>
                <td>ELAN</td>
                <td>
                  2.9% vs. 4.1%<br>
                  RD = -1.18% (-2.84 to 0.47)
                </td>
                <td>
                  3.7% vs. 5.6%<br>
                  RD = -1.92% (-3.82 to -0.02)
                </td>
                <td>
                  0.2% vs 0.2% at 30d
                </td>
              </tr>
              <tr>
                <td>TIMING</td>
                <td>NA</td>
                <td>6.89% vs. 8.68%<br>
                  RD = −1.79% (−5.31% to 1.74%)
                </td>
                <td>
                  0 vs. 0 at 90d
                </td>
              </tr>
              <br>
          </table>
          <div style="font-size: 1.8vmax;">
            RD = Risk Difference
          </div>
          <div class="ref">
            <a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2303048" target="_blank" style="color: inherit;">
              1. ELAN. NEJM 2023.
          </a> &nbsp;
          <a href="https://doi.org/10.1161/CIRCULATIONAHA.122.060666" target="_blank" style="color: inherit;">
              2. TIMING. Circulation 2022.
          </a>
          </div>
        </div>
      </div>


  </amp-carousel>

  <amp-selector id="carousel11Selector" class="tabs" role=tablist on="select:carousel11.goToSlide(index=event.targetOption)">
    <div option='0' class="dots" selected></div>
    <div option='1' class="dots"></div>
    <div option='2' class="dots"></div>
  </amp-selector>

  <div class="caption">
    In a patient with AF with acute ischemic stroke who has no contraindication to NOAC,
    NOAC may be initiated or resumed within one week. 
  </div>
</div>


<!--1.2 platelet-->
<div class="lightBlue"> 

  <div class="headLine">
    Cell-based Model of Hemostasis
  </div>

  <amp-carousel id="carousel12"
      height="1200"
      layout="fixed-height"
      type="slides"
      on="slideChange:carousel12Selector.toggle(index=event.index, value=true)">

      <!--cell based model-->
      <div class="container">
        <amp-youtube constrols noaudio autoplay loop
        data-videoid="ykNZ1-CmSsk"
        layout="fill"
        class="contain">
        </amp-youtube>
      </div>


  </amp-carousel>


  <div class="caption">
    1. Coagulation occurs on specific cell surfaces of tissue-factor (TF) bearing cells and platelets.<br>
    2. Thrombin activated platelets to recruit more platelet and enhance platelets aggregation.<br>
    3. Platelets then set the stage for a large scale of thrombin generation.<br> 
    4. Factor X also directly activates protease-activated receptiors (PARs) on platelets.
  </div>


</div>

<!--1.3 MHV-->
<div class="lightGrey"> 

  <div class="headLine">
    Thrombin Generation in Mechanical Heart Valve
  </div>

  <amp-carousel id="carousel13"
      height="1200"
      layout="fixed-height"
      type="slides"
      on="slideChange:carousel13Selector.toggle(index=event.index, value=true)">

      <!--mhv-->
      <div class="container">
        <!--amp-video controls noaudio autoplay loop 
        class="contain" layout="fill" title="coagCascade"
            <source src="video/MHV mp4.mp4" type="video/mp4">
        </amp-video-->
        <amp-youtube constrols noaudio autoplay loop
        data-videoid="SWli71vpFmg"
        layout="fill"
        class="contain">
        </amp-youtube>
        <div class="ref">
          <a href="https://doi.org/10.1182/blood-2002-08-2527" target="_blank" style="color: inherit;">
          Blood 2003.
          </a>&nbsp;
          <a href="https://doi.org/10.1161/jaha.115.002322" target="_blank" style="color: inherit;">
          J Am Heart Assoc 2015.
          </a>&nbsp;
          <a href="https://doi.org/10.1016/j.jacc.2016.09.958" target="_blank" style="color: inherit;">
          JACC 2016.
          </a>
        </div>
      </div>

      <!--noacs dose-->
      <div class="container">
        <amp-img src="media/noacDoseMHV.png" class="contain"
            layout="fill"></amp-img> 
        <div class="ref">  
        <a href="https://doi.org/10.1161/jaha.115.002322" target="_blank" style="color: inherit;">
              JAHA 2015.
        </a> &nbsp;
        <a href="https://doi.org/10.1016/j.athoracsur.2019.10.091" target="_blank" style="color: inherit;">
        Ann Thorac Surg 2020.
        </a>
        </div>
      </div>

      <!--mhv trials-->
      <div class="container">
        <div style="overflow-y: scroll;height: 100%;">
          <div style="padding: 0.5vmax;text-align: center;
          font-size: 2.5vmax;color:#19283d;font-weight: 900;">
          NOACs in Mechanical Heart Valve: Results from RCTs

          <table id="mhvTable">
            <tr>
              <td rowspan="2">Trials</td>
              <td rowspan="2">Valve</td>
              <td rowspan="2">Timing after Surgery</td>
              <td rowspan="2">NOAC</td>
              <td colspan="2">Results</td>
            </tr>
            <tr>
              <td>NOAC</td><td>VKA</td>
            </tr>
            <tr>
              <td>RE-ALIGN<br>N = 252, f/u 150d
              </td>
              <td>Bileaflet, Mitral and/or Aortic position</td>
              <td>Group A: within 7d<br>
                Group B: >3mos
              </td>
              <td>Dabigatran 150-300 mg BID</td>
              <td>
                Stroke: 5% <br>
                Major Bleeding: 4%
              </td>
              <td>
                Stroke: 0<br>
                Major Bleeding: 2%
              </td>
            </tr>
            <tr>
              <td>
              RIWA<br>N = 44; f/u 90d</td>
              <td>
                Bileaflet, Mitral and/or Aortic position
              </td>
              <td>> 3mos</td>
              <td>Rivaroxaban 15 mg BID</td>
              <td>Stroke: 0<br>
              Major Bleeding: 0
              </td>
              <td>
                Stroke: 2.95%<br>
                Major Bleeding: 0
              </td>
            </tr>
            <tr>
              <td>PROACT Xa<br>
                N = 863; f/u 13 mos
              </td>
              <td>On-X, Aortic position</td>
              <td>> 3mos</td>
              <td>
                Apixaban 5 mg BID<br>
                + ASA 81 mg in both arms
              </td>
              <td>
                Valve thrombosis: 4.2%/pt-yr<br>
                Stroke: 2.9%/pt-yr<br>
                Major Bleeding: 3.6%/pt-yr
              </td>
              <td>
                Valve thrombosis: 1.3%/pt-yr<br>
                Stroke: 0<br>
                Major Bleeding: 4.5%/pt-yr
              </td>
            </tr>

          </table>

          <div class="ref">
            <a href="https://doi.org/10.1056/nejmoa1300615" target="_blank" style="color: inherit;">
              RE-ALIGN. NEJM 2013.
          </a> &nbsp;
          <a href="https://doi.org/10.1007/s40256-020-00449-3" target="_blank" style="color: inherit;">
              RIWA. Am J Cardiovasc Drugs 2021.
          </a> &nbsp;
          <a href="https://evidence.nejm.org/doi/10.1056/EVIDe2300106" target="_blank" style="color: inherit;">
            PROACT Xa. NEJM Evid 2023.
          </a>
          </div>
        </div>
      </div>
      </div>

  </amp-carousel>

  <amp-selector id="carousel13Selector" class="tabs" role=tablist on="select:carousel13.goToSlide(index=event.targetOption)">
    <div option='0' class="dots" selected></div>
    <div option='1' class="dots"></div>
    <div option='2' class="dots"></div>
 
  </amp-selector>

  <div class="caption">
  1. The rate and amount of thrombin generation is the major determinant of clot structure.<br>
  2. Mechanical heart valve generates thrombin via intrinsic pathway.<br>
  3. In patients with mechanical heart valve(s), NOACs are not recommended.
  </div>
</div>
  
  <!--2 CKD-->
  <div class="creme">
  <div class="headLine">
    Coagulation System in Advanced Chronic Kidney Disease
  </div>

  <amp-carousel id="carousel2"
      height="1200"
      layout="fixed-height"
      type="slides"
      on="slideChange:carousel2Selector.toggle(index=event.index, value=true)"
      >
      <!--ckd mp4-->
      <div class="container">
        <amp-video controls noaudio autoplay loop 
        class="contain" layout="fill" title="coagCascade"
            <source src="video/ckd.mp4" type="video/mp4">
        </amp-video>
        <div class="ref">
          <a href="https://doi.org/10.1136/bmjopen-2016-014294" target="_blank" style="color: inherit;">
          BMJ Open 2017.
          </a>&nbsp;
          <a href="https://doi.org/10.1111/jth.15653" target="_blank" style="color: inherit;">
            J Thromb Haemost 2022. 
          </a>
        </div>
      </div>

      <!--trials-->
      <div class="container">
        <amp-img src="media/ckdTrials.png"
        layout="fill"
        class="contain"></amp-img>
        <div class="ref">
        <a href="https://doi.org/10.1681/asn.2020111566" target="_blank" style="color: inherit;">
          VALKYRIE. J Am Soc Nephrol 2021.
        </a> &nbsp;
        <a href="https://doi.org/10.1161/CIRCULATIONAHA.122.062779" target="_blank" style="color:inherit">
          AXADIA AFNET8. Circulation 2023.
        </a>
        </div>
      </div>

    <!--ckd guidelines-->
    <div class="container">
      <div style="overflow-y: scroll;height: 100%;">
        <div style="padding: 0.5vmax;text-align: center;
        font-size: 2.5vmax;color:#19283d;font-weight: 900;">
        Guidelines Recommendation for use of OAC in AF with GFR&lt;15ml/min or on dialysis.

        <table id="ckdTable">
          <tr>
            <th>Guideline</th>
            <th>VKA</th><th>Rivaroxaban</th>
            <th>Apixaban</th><th>Dabigatran</th><th>Edoxaban</th>
          </tr>
          <tr>
            <td>KDIGO 2018</td>
            <td>Equipoise</td>
            <td>Unknown</td><td>Unknown</td>
            <td>Not recommended</td><td>Not recommended</td>
          </tr>
          <tr>
            <td>ACC 2019</td>
            <td>IIb</td>
            <td>Not recommended</td>
            <td>IIb</td>
            <td>Not recommended</td><td>Not recommended</td>
          </tr>
          <tr>
            <td>CCS 2020</td>
            <td colspan="5">
              Should not routinely receive antithromotic therapy.
            </td>
          </tr>
          <tr>
            <td>ESC 2020</td>
            <td colspan="5">
              No solid evidence. Not recommended.
            </td>
          </tr>
          <tr>
            <td>Expert Opinions 2023</td>
            <td colspan="5">
              1. Bleeding > Stroke in AF on dialysis. Should OAC be given at all?<br>
              2. Should VKA be avoided after VALKYRIE and AXADIA?<br>
              3. In selected patients, Rivaroxaban and Apixaban may be used. 
            </td>
          </tr>
        </table>

        <div class="ref" style="font-weight: 400;">
          <a href="https://doi.org/10.1093/eurheartj/ehy060" target="_blank" style="color: inherit;">
            KDIGO 2018
        </a> &nbsp;
        <a href="https://doi.org/10.1016/j.jacc.2019.01.011" target="_blank" style="color: inherit;">
            ACC 2019
        </a> &nbsp;
        <a href="https://doi.org/10.1016/j.cjca.2020.09.001" target="_blank" style="color: inherit;">
          CCS 2020
        </a>&nbsp;
        <a href="https://doi.org/10.1093/eurheartj/ehaa612" target="_blank" style="color: inherit;">
          ESC 2020
        </a>&nbsp;
        <a href="https://doi.org/10.1016/j.kint.2023.03.027" target="_blank" style="color: inherit;">
          Kidney Internation 2023
        </a>&nbsp;
        <a href="https://doi.org/10.1016/j.xkme.2023.100690" target="_blank" style="color: inherit;">
          Kidney Med 2023
        </a>&nbsp;
        <a href="https://doi.org/10.1016/j.jacasi.2023.03.004" target="_blank" style="color: inherit;">
          JACC Asia 2023
        </a>

        </div>
      </div>
    </div>
    </div>


   
  </amp-carousel>

  <amp-selector id="carousel2Selector" class="tabs" role=tablist on="select:carousel2.goToSlide(index=event.targetOption)"
    layout="container" style="text-align: center;">
      <span option='0' class="dots" selected></span>
      <span option='1' class="dots"></span>
      <span option='2' class="dots"></span>
  </amp-selector>

  <div class="caption">
    Roles of OAC in AF on dialysis remain unresolved.
  </div>
  </div>
  

  <!--3 FXI-->
  <div class="lightBlue">
  <div id="no3" class="headLine">
    Modern Concept of Coagulation Pathway
  </div>

  <amp-carousel id="carousel3"
      height="1200"
      layout="fixed-height"
      type="slides"
      on="slideChange:carousel3Selector.toggle(index=event.index, value=true)"
      >

      <!--uncoupling cascade-->
      <div class="container">
        <!--amp-video controls noaudio autoplay loop 
        class="contain" layout="fill" title="coagCascade"
            <source src="video/animateHeart.mp4" type="video/mp4">
        </amp-video-->
        <amp-youtube constrols noaudio autoplay loop
        data-videoid="K5l43I5QDRM"
        layout="fill"
        class="contain">
        </amp-youtube>
        <div class="ref">
          <a href="https://doi.org/10.1161/01.ATV.0000193624.28251.83" target="_blank" style="color: inherit;">
            Arterioscler Thromb Vasc Biol. 2006 
          </a>&nbsp;
          <a href="https://doi.org/10.1016/j.jacc.2021.06.010" target="_blank" style="color: inherit;">
            JACC 2021.
          </a>
        </div>
      </div>

    <!--FXI-->
    <div class="container">
      <amp-img src="media/fx1.jpg"
      layout="fill"
      class="contain"></amp-img>
      <a href="https://doi.org/10.1016/j.jacc.2022.11.057" target="_blank" class="ref">
        JACC 2023.</a>
    </div>

    <!--Pacific AF-->
    <div class="container">
      <amp-img src="media/pacificAF.png"
      layout="fill"
      class="contain"></amp-img>
      <a href="https://doi.org/10.1016/s0140-6736(22)00456-1" target="_blank" class="ref">
        PACIFIC AF. Lancet 2022.</a>
    </div>


  </amp-carousel>

  <amp-selector id="carousel3Selector" class="tabs" role=tablist on="select:carousel3.goToSlide(index=event.targetOption)"
    layout="container" style="text-align: center;">
      <span option='0' class="dots" selected></span>
      <span option='1' class="dots"></span>
      <span option='2' class="dots"></span>
  </amp-selector>

  <div class="caption" style="text-align: left;">
    1. Modern concept of coagulation pathway suggest that pathologic thrombosis and physiologic hemostasis pathways are separated.<br>
    2. Factor XI inhibitors may serve as hemostasis-sparing anticoagulants.<br>
    3. In a phase 2 study, Asundexian, an oral factor XI inhibitor, was associated with lower rate of bleeding than Apixaban in patients with AF.
  </div>
  </div>

  <!--4 conclusion-->
  <div class="lightBlue">
    <div id="no4" class="headLine">
      Conclusions
    </div>
  
    <amp-carousel id="carousel4"
        height="1200"
        layout="fixed-height"
        type="slides"
        on="slideChange:carousel4Selector.toggle(index=event.index, value=true)"
        >
   
      <!--perfect clot-->
      <div class="conclusion">
        <div style="width: 100%;height: 100%;overflow-y: scroll;">
        <div style="width: fit-content;margin-left: auto;margin-right: auto;padding:1.5vmax;">
          <div style="font-size: 3vmax;color: #e0d9be;padding-top: 2vh;padding-left: 1vmax;">
            Perfect Clot requires:
          </div>
          <ol style="list-style-type:decimal-leading-zero;padding: 1vmax;
          color: #d8d8d8;list-style-position: inside;font-size: 2vmax;">
            <li>Right amount of coagulation factors</li>
            <li>Right steps of platelet activation</li>
            <li>Right amount and pattern of thrombin generation</li>
          </ol>
        </div>
        </div>
      </div>
      <!--NOAC-->
      <div class="conclusion">
        <div style="width: 100%;height: 100%;overflow-y: scroll;">
        <div style="width: fit-content;margin-left: auto;margin-right: auto;padding:1vmax;">
          <div style="font-size: 3vmax;color: #fa7268;padding-top: 2vh;padding-left: 1vmax;">
            NOAC 2023 Update
          </div>
          <ol style="list-style-type:decimal-leading-zero;padding: 1vmax;color: #d8d8d8;list-style-position: inside;
          font-size: 2vmax;">
            <li>
              NOAC may be resumed within 4-7d after acute ischemic stroke with AF.
            </li>
            <li>
              Role of OAC in AF on dialysis remains unsettled.
            </li>
            <li>
              FXI inhibitor may serve as a hemostasis-sparing anticoagulant.
            </li>
          </ol>
        </div>
        </div>
      </div>
  
  
    </amp-carousel>
  
    <amp-selector id="carousel4Selector" class="tabs" role=tablist on="select:carousel4.goToSlide(index=event.targetOption)"
      layout="container" style="text-align: center;">
        <span option='0' class="dots" selected></span>
        <span option='1' class="dots"></span>
    </amp-selector>
  
    <div class="caption" style="text-align: left;">
    </div>
    </div>

  <!--footer-->
  <div style="background: #ddd;font-size: 1.4vmax;padding:5vmax 3vmax;color:#555;line-height: 200%;text-align: center;">
   
      
    <div id="about">
      <div style="max-width: 600px;margin-left: auto;margin-right: auto;text-align: center;">
          <div style="padding-bottom: 2vh;">
              <a href="#top" style="text-decoration:none;color:#555;">
                  &uarr;&nbsp;<b>Top</b> of the page</a>
          </div>  
          <div style="padding-bottom: 2vh;">
                  <a href="https://heartRhythmBox.com/" target="_blank" 
                  style="text-decoration:none;color: #555;">
                      <img src="boxGrey.png" style="width: 37px;">
                  </a> &nbsp;&nbsp;
                  <a href="https://www.youtube.com/channel/UCb9nCPfRKR_F2ppLaYZC43w/featured" 
                  target="_blank" style="text-decoration:none;color: #555;">
                      <img src="youTube.png" style="width: 38px;">
                  </a>
          </div>
          <div style="font-size: 13px;padding: 2vh 1vw;border-top: #555 0.1vmax solid;color: #555;text-align: justify;">
              Heart Rhythm Box is a collection of web-paged style presentations in clinical cardiac electrophysiology topics.
              The page is created mainly for educational purpose. 
          </div>
          <div style="font-size: 13px;padding: 2vh 1vw;border-top: #555 0.1vmax solid;color: #555;
          text-align: center;font-weight: 700;">
              &copy;&nbsp;&nbsp;CODING OF A KIND<br>
              <span style="font-weight: 400;">
              design to your style &middot; write to your need</span>
          </div>

  </div>

</body>
</html>